Applications of tacrolimus for the treatment of skin disorders (Q33957194)

30 July 2017

1 reference

title

Applications of tacrolimus for the treatment of skin disorders (English)

1 reference

30 July 2017

Assmann T

1

1 reference

PubMed ID

10878290

30 July 2017

Homey B

series ordinal

2

1 reference

PubMed ID

10878290

30 July 2017

Ruzicka T

series ordinal

3

1 reference

30 July 2017

1 May 2000

1 reference

30 July 2017

1 reference

30 July 2017

47

1 reference

30 July 2017

2-3

1 reference

30 July 2017

203-213

1 reference

Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Pathogenesis of atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

1 reference

7 January 2021

The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Atopic dermatitis: recent trends in pathogenesis and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Anti-inflammatory effect of FK-506 on human skin mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Prospective study of FK506 side effects: anxiety or akathisia?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Modulation of histamine release in vitro by FK506 and interleukin-3 is determined by sequence of incubation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Clearance of severe psoriasis after allogenic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Cyclosporin wash for oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

The genetics of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Lesional expression of interferon-gamma in atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Lichen planus and liver diseases: a multicentre case-control study. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED)

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

A local lymph node assay to analyse immunosuppressive effects of topically applied drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Topical FK506--clinical potential or laboratory curiosity?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Absorption of topical tacrolimus (FK506) in vitro through human skin: comparison with cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

1 reference

7 January 2021

Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus (FK506)

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

FK506 in the treatment of inflammatory skin disease: promises and perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Tacrolimus ointment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

CD4 antibody treatment of severe psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Cyclosporin in less common immune-mediated skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Murine psoriasis-like disorder induced by naive CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Topical tacrolimus for pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Mechanism of fibrosis in experimental tacrolimus nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

FK 506 for liver, kidney, and pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Cyclosporine therapy in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

FK-506 enters the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Liver, kidney, and thoracic organ transplantation under FK 506.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Erosive mucosal lichen planus: response to topical treatment with tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Disturbance of HL-A Antigen Frequency in Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Acute and chronic nephrotoxicity associated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

FK506-induced neurotoxicity in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900187-9

7 January 2021

10.1016/S0162-3109(00)00187-9

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10878290